{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:57:36Z","timestamp":1760245056830,"version":"3.44.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jim.2021.113041","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T18:06:40Z","timestamp":1616177200000},"page":"113041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy"],"prefix":"10.1016","volume":"494","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Cham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunobu","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debrah","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.","family":"Kerns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2021.113041_bb0005","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol."},{"issue":"18","key":"10.1016\/j.jim.2021.113041_bb0010","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1158\/1078-0432.CCR-13-1253","article-title":"Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy","volume":"19","author":"Beard","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"169","key":"10.1016\/j.jim.2021.113041_bb0015","article-title":"Improved cell composition deconvolution method of bulk gene expression profiles to quantify subsets of immune cells","volume":"12","author":"Chiu","year":"2019","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.jim.2021.113041_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2105-4-59","article-title":"Cross-platform comparison and visualisation of gene expression data using co-inertia analysis","volume":"4","author":"Culhane","year":"2003","journal-title":"BMC Bioinformat."},{"key":"10.1016\/j.jim.2021.113041_bb0025","article-title":"Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer","volume":"10611","author":"Fong","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.jim.2021.113041_bb0030","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/bioinformatics\/16.10.906","article-title":"Support vector machine classification and validation of cancer tissue samples using microarray expression data","volume":"16","author":"Furey","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jim.2021.113041_bb0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.coi.2010.11.013","article-title":"Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment","volume":"23","author":"Gajewski","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"1\u20133","key":"10.1016\/j.jim.2021.113041_bb0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1023\/A:1012487302797","article-title":"Gene selection for cancer classification using support vector machines","volume":"46","author":"Guyon","year":"2002","journal-title":"Mach. Learn."},{"issue":"1","key":"10.1016\/j.jim.2021.113041_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1486953","article-title":"Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer","volume":"8","author":"Hagihara","year":"2019","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.jim.2021.113041_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biopha.2018.05.119","article-title":"Plasminogen activator inhibitor-1 in cancer research","volume":"105","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jim.2021.113041_bb0055","article-title":"UMAP: uniform manifold approximation and projection for dimension reduction","volume":"03426","author":"McInnes","year":"2018","journal-title":"ArXiv e-prints"},{"issue":"9","key":"10.1016\/j.jim.2021.113041_bb0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrclinonc.2014.111","article-title":"Therapeutic vaccines for cancer: an overview of clinical trials","volume":"11","author":"Melero","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.jim.2021.113041_bb0065","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.jim.2021.113041_bb0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1677\/ERC-09-0109","article-title":"Emerging roles of chemokines in prostate cancer","volume":"16","author":"Vindieux","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"issue":"11","key":"10.1016\/j.jim.2021.113041_bb0075","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/2326-6066.CIR-16-0042","article-title":"Systemic GM-CSF recruits effector t cells into the tumor microenvironment in localized prostate cancer","volume":"4","author":"Wei","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jim.2021.113041_bb0080","doi-asserted-by":"crossref","first-page":"26605","DOI":"10.1038\/srep26605","article-title":"Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:35:34Z","timestamp":1758299734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175921000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":16,"alternative-id":["S0022175921000867"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2021.113041","relation":{},"ISSN":["0022-1759"],"issn-type":[{"type":"print","value":"0022-1759"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2021.113041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113041"}}